Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism: Review

Journal of Internal Medicine

Volumn 268, Issue 4, 2010, Pages 320-328

  Caesar, R ^a   Fa k F ^a   Backhed F ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

atherosclerosis; gut microbiota; obesity; toll like receptor

Indexed keywords

CHOLESTEROL; CHYLOMICRON; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN; PREBIOTIC AGENT; PROBIOTIC AGENT; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHOLESTEROL TRANSPORT; DIET THERAPY; ENTEROCOCCUS FAECIUM; ENVIRONMENTAL FACTOR; EPITHELIUM; HUMAN; INFECTION; INFLAMMATION; INNATE IMMUNITY; INSULIN RESISTANCE; INTESTINE ABSORPTION; INTESTINE FLORA; LACTOBACILLUS DELBRUECKII; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; LIPID ABSORPTION; LIPID METABOLISM; MACROPHAGE; MICROBIAL COMMUNITY; NONHUMAN; OBESITY; POPULATION DENSITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; TIGHT JUNCTION; TISSUE EXPANSION;

ATHEROSCLEROSIS; BIOLOGICAL TRANSPORT; GASTROINTESTINAL TRACT; HUMANS; IMMUNITY, INNATE; INTESTINAL ABSORPTION; LIPID METABOLISM; LIPOPOLYSACCHARIDES; METAGENOME; OBESITY; TOLL-LIKE RECEPTORS;

EID: 77956310020     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2010.02270.x     Document Type: Review

References (91)

1. Bäckhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science 2005 307 : 1915 1920.
2. Bäckhed F, Manchester JK, Semenkovich CF, Gordon JI. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A 2007 104 : 979 984.
3. Bäckhed F, Ding H, Wang T et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 2004 101 : 15718 15723.
4. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006 444 : 1027 1031.
5. Velagapudi VR, Hezaveh R, Reigstad CS et al. The gut microbiota modulates host energy and lipid metabolism in mice. J Lipid Res 2010 51 : 1101 1112.
6. Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A 2005 102 : 11070 11075.
7. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology:human gut microbes associated with obesity. Nature 2006 444 : 1022 1023.
8. Turnbaugh PJ, Hamady M, Yatsunenko T et al. A core gut microbiome in obese and lean twins. Nature 2009 457 : 480 484.
9. Cani PD, Delzenne NM. The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des 2009 15 : 1546 1558.
10. Cani PD, Delzenne NM. Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota. Curr Opin Pharmacol 2009 9 : 737 743.
11. Musso G, Gambino R, Cassader M. Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders. Curr Opin Lipidol 2010 21 : 76 83.
12. Turnbaugh PJ, Gordon JI. The core gut microbiome, energy balance and obesity. J Physiol 2009 587 : 4153 4158.
13. Vrieze A, Holleman F, Zoetendal EG, de Vos WM, Hoekstra JB, Nieuwdorp M. The environment within: how gut microbiota may influence metabolism and body composition. Diabetologia 2010 53 : 606 613.
14. Bäckhed F, Crawford PA. Coordinated regulation of the metabolome and lipidome at the host-microbial interface. Biochim Biophys Acta 2010 1801 : 240 245.
15. Reinhardt C, Reigstad CS, Bäckhed F. Intestinal microbiota during infancy and its implications for obesity. J Pediatr Gastroenterol Nutr 2009 48 : 249 256.
16. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006 124 : 783 801.
17. Beutler B. Inferences, questions and possibilities in toll-like receptor signalling. Nature 2004 430 : 257 263.
18. Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 2006 6 : 823 835.
19. Hotamisligil GS, Erbay E. Nutrient sensing and inflammation in metabolic diseases. Nat Rev Immunol 2008 8 : 923 934.
20. Johnson GB, Riggs BL, Platt JL. A genetic basis for the "Adonis" phenotype of low adiposity and strong bones. FASEB J 2004 18 : 1282 1284.
21. Tsukumo DML, Carvalho-Filho MA, Carvalheira JBC et al. Loss-of-function mutation in toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 2007 56 : 1986 1998.
22. Saberi M, Woods NB, de Luca C et al. Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice. Cell Metab 2009 10 : 419 429.
23. Vijay-Kumar M, Aitken JD, Carvalho FA et al. Metabolic syndrome and altered gut microbiota in mice lacking toll-like receptor 5. Science 2010 328 : 228 231.
24. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005 115 : 1111 1119.
25. Berg RD. The indigenous gastrointestinal microflora. Trends Microbiol 1996 4 : 430 435.
26. Goto T, Eden S, Nordenstam G, Sundh V, Svanborg-Eden C, Mattsby-Baltzer I. Endotoxin levels in sera of elderly individuals. Clin Diagn Lab Immunol 1994 1 : 684 688.
27. Wiedermann CJ, Kiechl S, Dunzendorfer S et al. Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the bruneck study. J Am Coll Cardiol 1999 34 : 1975 1981.
28. Bölke E, Jehle PM, Storck M, Nothnagel B, Stanescu A, Orth K. Endotoxin release and endotoxin neutralizing capacity during colonoscopy. Clin Chim Acta 2001 303 : 49 53.
29. Niebauer J, Volk H-D, Kemp M et al. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 1999 353 : 1838 1842.
30. Nadhazi Z, Takats A, Offenmuller K, Bertok L. Plasma endotoxin level of healthy donors. Acta Microbiol Immunol Hung 2002 49 : 151 157.
31. Creely SJ, McTernan PG, Kusminski CM et al. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 2007 292 : E740 7.
32. Cani PD, Amar J, Iglesias MA et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007 56 : 1761 1772.
33. Reigstad CS, Lunden GO, Felin J, Backhed F. Regulation of serum amyloid A3 (SAA3) in mouse colonic epithelium and adipose tissue by the intestinal microbiota. PLoS ONE 2009 4 : e5842.
34. Hornef MW, Frisan T, Vandewalle A, Normark S, Richter-Dahlfors A. Toll-like receptor 4 resides in the golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells. J Exp Med 2002 195 : 559 570.
35. Sabesin SM, Frase S. Electron microscopic studies of the assembly, intracellular transport, and secretion of chylomicrons by rat intestine. J Lipid Res 1977 18 : 496 511.
36. Ghoshal S, Witta J, Zhong J, de Villiers W, Eckhardt E. Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res 2009 50 : 90 7.
37. Erridge C, Attina T, Spickett CM, Webb DJ. A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr 2007 86 : 1286 1292.
38. Amar J, Burcelin R, Ruidavets JB et al. Energy intake is associated with endotoxemia in apparently healthy men. Am J Clin Nutr 2008 87 : 1219 1223.
39. Brun P, Castagliuolo I, Leo VD et al. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2007 292 : G518 25.
40. Cani PD, Bibiloni R, Knauf C et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008 57 : 1470 1481.
41. Cani PD, Neyrinck AM, Fava F et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007 50 : 2374 2383.
42. Cani PD, Possemiers S, Van de Wiele T et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009 58 : 1091 1103.
43. Cinti S, Mitchell G, Barbatelli G et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 2005 46 : 2347 2355.
44. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007 117 : 175 184.
45. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003 112 : 1796 1808.
46. Xu H, Barnes GT, Yang Q et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003 112 : 1821 1830.
47. Wostmann BS, Larkin C, Moriarty A, Bruckner-Kardoss E. Dietary intake, energy metabolism, and excretory losses of adult male germfree Wistar rats. Lab Anim Sci 1983 33 : 46 50.
48. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006 116 : 3015 3025.
49. Nguyen MT, Favelyukis S, Nguyen AK et al. A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via toll-like receptors 2 and 4 and JNK-dependent pathways. J Biol Chem 2007 282 : 35279 35292.
50. Suganami T, Tanimoto-Koyama K, Nishida J et al. Role of the toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol 2007 27 : 84 91.
51. Gao Z, Hwang D, Bataille F et al. Serine phosphorylation of insulin receptor substrate 1 by inhibitor κB kinase complex. J Biol Chem 2002 277 : 48115 48121.
52. Aguirre V, Uchida T, Yenush L, Davis R, White MF. The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser307. J Biol Chem 2000 275 : 9047 9054.
53. Arkan MC, Hevener AL, Greten FR et al. IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 2005 11 : 191 198.
54. Solinas G, Vilcu C, Neels JG et al. JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell Metab 2007 6 : 386 397.
55. Clarke TB, Davis KM, Lysenko ES, Zhou AY, Yu Y, Weiser JN. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat Med 2010 16 : 228 231.
56. Monaco C, Gregan S, Navin T, Foxwell B, Davies A, Feldmann M. Toll-like receptor-2 mediates inflammation and matrix degradation in human atherosclerosis. Circulation 2009 120 : 2462 2469.
57. Kiechl S, Lorenz E, Reindl M et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 2002 347 : 185 192.
58. Michelsen K, Wong M, Shah P et al. Lack of toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci U S A 2004 101 : 10679 10684.
59. Mullick AE, Tobias PS, Curtiss LK. Modulation of atherosclerosis in mice by toll-like receptor 2. J Clin Invest 2005 115 : 3149 3156.
60. Björkbacka H, Kunjathoor V, Moore K et al. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat Med 2004 10 : 416 421.
61. Tall AR, Yvan-Charvet L, Terasaka N, Pagler T, Wang N. HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis. Cell Metab 2008 7 : 365 375.
62. Repa JJ, Mangelsdorf DJ. The liver X receptor gene team: potential new players in atherosclerosis. Nat Med 2002 8 : 1243 1248.
63. Castrillo A, Joseph SB, Vaidya SA et al. Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. Mol Cell 2003 12 : 805 816.
64. Smoak KA, Aloor JJ, Madenspacher J et al. Myeloid differentiation primary response protein 88 couples reverse cholesterol transport to inflammation. Cell Metab 2010 11 : 493 502.
65. Epstein SE, Zhu J, Burnett MS, Zhou YF, Vercellotti G, Hajjar D. Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry. Arterioscler Thromb Vasc Biol 2000 20 : 1417 1420.
66. Desvarieux M, Demmer R, Rundek T et al. Periodontal microbiota and carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Circulation 2005 111 : 576 582.
67. Mei C, He P, Cheng B, Liu W, Wang Y, Wan J. Chlamydia pneumoniae induces macrophage-derived foam cell formation via PPAR a and PPAR g-dependent pathways. Cell Biol Int 2009 33 : 301 308.
68. Ott SJ, El Mokhtari NE, Musfeldt M et al. Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease. Circulation 2006 113 : 929 937.
69. Chen S, Sorrentino R, Shimada K et al. Chlamydia pneumoniae-induced foam cell formation requires MyD88-dependent and -independent signaling and is reciprocally modulated by liver X receptor activation. J Immunol 2008 181 : 7186 7193.
70. Jaff M, Dale R, Creager M et al. Anti-chlamydial antibiotic therapy for symptom improvement in peripheral artery disease: prospective evaluation of rifalazil effect on vascular symptoms of intermittent claudication and other endpoints in Chlamydia pneumoniae seropositive patients (PROVIDENCE-1). Circulation 2009 119 : 452 458.
71. Andraws R, Berger J, Brown D. Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials. JAMA 2005 293 : 2641 2647.
72. Muhlestein J. Antibiotic treatment of atherosclerosis. Curr Opin Lipidol 2003 14 : 605 614.
73. Mattila KJ, Nieminen MS, Valtonen VV et al. Association between dental health and acute myocardial infarction. BMJ 1989 298 : 779 781.
74. Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ. Identification of periodontal pathogens in atheromatous plaques. J Periodontol 2000 71 : 1554 1560.
75. Kozarov EV, Dorn BR, Shelburne CE, Dunn WA Jr., Progulske-Fox A. Human atherosclerotic plaque contains viable invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. Arterioscler Thromb Vasc Biol 2005 25 : e17 8.
76. Stelzel M, Conrads G, Pankuweit S et al. Detection of Porphyromonas gingivalis DNA in aortic tissue by PCR. J Periodontol 2002 73 : 868 870.
77. Gaetti-Jardim E Jr., Marcelino SL, Feitosa AC, Romito GA, Avila-Campos MJ. Quantitative detection of periodontopathic bacteria in atherosclerotic plaques from coronary arteries. J Med Microbiol 2009 58 : 1568 1575.
78. Gibson FC III., Hong C, Chou HH et al. Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation 2004 109 : 2801 2806.
79. de Oliveira C, Watt R, Hamer M. Toothbrushing, inflammation, and risk of cardiovascular disease: results from Scottish Health Survey. BMJ 2010 340 : c2451.
80. Ridker PM, Cannon CP, Morrow D et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med 2005 352 : 20 8.
81. Stepankova R, Tonar Z, Bartova J et al. Absence of microbiota (germ-free conditions) accelerates the atherosclerosis in ApoE-deficient mice fed standard low cholesterol diet. J Atheroscler Thromb 2010 Apr 2 (Epub ahead of print).
82. Wright S, Burton C, Hernandez M et al. Infectious agents are not necessary for murine atherogenesis. J Exp Med 2000 191 : 1437 1442.
83. Taranto M, Medici M, Perdigon G, Ruiz Holgado A, Valdez G. Effect of Lactobacillus reuteri on the prevention of hypercholesterolemia in mice. J Dairy Sci 2000 83 : 401 403.
84. Andrade S, Borges N. Effect of fermented milk containing Lactobacillus acidophilus and Bifidobacterium longum on plasma lipids of women with normal or moderately elevated cholesterol. J Dairy Sci 2009 76 : 469 474.
85. Luoto R, Kalliomäki M, Laitinen K, Isolauri E. The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years. Int J Obes (Lond) 2010 Mar 16 (Epub ahead of print).
86. Kadooka Y, Sato M, Imaizumi K et al. Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur J Clin Nutr 2010 64 : 636 643.
87. Portugal L, Gonçalves J, Fernandes L et al. Effect of Lactobacillus delbrueckii on cholesterol metabolism in germ-free mice and on atherogenesis in apolipoprotein E knock-out mice. Braz J Med Biol Res 2006 39 : 629 635.
88. Rault-Nania M, Gueux E, Demougeot C, Demigné C, Rock E, Mazur A. Inulin attenuates atherosclerosis in apolipoprotein E-deficient mice. Br J Nutr 2006 96 : 840 844.
89. Cavallini D, Bedani R, Bomdespacho L, Vendramini R, Rossi E. Effects of probiotic bacteria, isoflavones and simvastatin on lipid profile and atherosclerosis in cholesterol-fed rabbits: a randomized double-blind study. Lipids Health Dis 2009 8 : doi:.
90. Naruszewicz M, Johansson M, Zapolska-Downar D, Bukowska H. Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers. Am J Clin Nutr 2002 76 : 1249 1255.
91. Ley RE. Obesity and the human microbiome. Curr Opin Gastroenterol 2010 26 : 5 11.